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The physico-chemical properties and the stability of 
anthralin, a potent anti psoriatic agent, h a s been inves-
tigated in model systems by optical absorption and flu-
orescence spectroscopy and by gas chromatography cou-
pled to mass spectrometry. Systematic studies were car-
ried out on anthralin and its oxidation products (1,8-
dihydroxyanthraquinone and 1,8-1',8'-tetrahydroxy-
dianthron). Anthralin and 1,8-dihydroxyanthraquinone 
are shown to readily bind to human serum albumin and 
not to DNA. Anthralin bound to albumin readily oxidizes, 
yielding the 1,8-dihydroxyanthraquinone which is fairly 
stable. These results are correlated with those obtained 
with intact whole human epidermis and suction blister 
fluid showing that, in the former case, anthralin binds to 
protein as suggested by absorption and fluorescence 
spectroscopies. Gas chromatography- mass spectrome-
try analysis make s it easy to detect anthralin and 1,8-
dihydroxyanthraquinone in suction blister fluid doped 
with anthralin but not in suction blister obtained after 
topical application on normal human skin. 
Anthralin is largely used in dermatology as a potent antipso-
riatic drug [1, 2]. However anthralin is a very unsta ble product 
easily oxidized to numerous compounds [3,4]' Thus, it is ac-
tually uncertain whether the molecular events leading to its 
therapeutic efficiency are linked to anthralin itself or to break-
down oxidation products liberated into the skin. For example, 
it has been recently shown that the so-called "anthralin brown" 
inhibits glucose-6-phosphate dehydrogenase (G6PDH), an en-
zyme which is thought to be involved to some exten t in the 
abnormal cell proliferation characterizing psoriasis [5, 6]. More-
over, most biological studies on antlu-alin were performed under 
physicochemical conditions in which anUu-alin is quickly de-
stroyed and, as a consequenc·e, the results al'e difficult to 
interpret. 
The aim of this study was to investigate the physicochemical 
properties of anthI'alin and its oxidation products in model 
media by absorption and fluorescence spectroscopies and gas 
chromatography coupled to mass spectrometry (GCMS) in 
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DMF: dimethylformamide 
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SIM: single ion moni toring technique 
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order to obtain more information required by future biological 
studies. 
On the basis of the information gathered in model systems, 
the stability of anthI'alin was studied in whole human epide rmis 
and in the interstitial fluid after in vitro incubation and in vivo 
topical application. 
EXPERIMENTAL 
Chemicals of the purest commercially available grade were 
used as received. Purified antlu-alin (I) , 1,8-dihydroxyant hra-
quinone (II) and 1,8-1',8'-tetrahydroxydianthron (III) we re a 
gift of Dr. B. Shrott (C.LR D. 06 Val bonne, France). T hey 
were kept frozen (-22°C) in the dark. Absorption spectra in 
ethanol were taken from time to time in order to check t heir 
stability. Tris and phosphate buffers at various ionic stren gths 
and pH were prepared in triply distilled water. Solvents such 
as ethanol, acetone, chloroform, and dimethylformamide were 
Merck UV ASOL grade products. Bovine and human selUm 
albumins (BSA or HS A) were supplied by Sigma as well as 
DNA from calf-thymus. 
Optical spectra on the skin samples were recorded with a 
Cary 219 spectrophotometer while fluorescence measurements 
were performed with either an Aminco-Bowman spectrofluo-
rophosphorirneter or a FICA 50 M fluorin1eter equipped w ith 
excitation and emission spectrum corrections. When anaerobic 
conditions were required, spectrophotometry was performe d in 
solutions bubbled with argon or nitrogen provided by Air Liq-
uide. 
Intact human skin samples (- 2 cm2) were obtained from 
blisters induced by mild suction as alr eady described (7). T hey 
were kept in Hanks' culture medium devoid of phenol red. S kin 
samples were obtained from areas that had been treated one 
day before spectrophotometric analysis with an thral in (oint-
ment or 0.5% solutions) as specified in some figure legends. 
Untreated skin samples were, in some cases, incubated in the 
dark with anthralin in H anks' medium. In this case, the incu-
bation medium was prepared by adding up to 2% of a 10- 2 M 
stock anthI·alin solution in either etha.nol or acetone to the 
desired volume of H anks' medium. Incubation t imes were u p to 
3 hI·. Because of anthI'alin instabili ty, solutions were handled in 
the dark and kept under nitrogen. 
The skin samples thus obta ined have a good light t ransmis-
sion up to - 350 nm [8] so t hat optical absorption spectroscopy 
can be directly performed on human epidermis. In this regard, 
6-mm diameter circular skin patches (thickness 50 }Lm ) were cut 
with a puncher and placed into 0.1 mm opt ical quartz cells . In 
order to obtain good base lines an untreated blank skin sample 
prepar ed in t he same way was intercalated into t he refere nce 
beam of the spectrophotometer. 
The blister fluid which is a good representative of the inter-
stit ial fluid [9] was analyzed by optical spectroscopy an d gas 
chI·omatography coupled to mass spectrometry (GCMS). A 
Hewlett Packard type H P 5992 B Mass spectrometer coup led 
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with a gas chromatographer equipped with a 25 m X 0.3 mm 
i.d . glass capillary column coated with SE-30 was used. Helium 
ftltered on molecular sieve was used as a carrier gas at a flow 
rate of 2 rnI/min. Instrument temperatures were-injector: 
189°C-oven from 180° to 280°C (with temperature program-
ming: 6° per min). The mass spectrometer was used under the 
following conditions: accelerating voltage 1800 V, ionization 
energy 70 ev. 
Biological materials were first extracted by acetone and then 
by benzene. After evaporation of the solvent under a nitrogen 
stream, residues were silylated with a mixture of bistrimethyl-
silyl tritluoroacetamine (BSTF A) and trimethylchlorosilane 
(TMCS) (80/20 v/v), in a screw-capped septum vial, heated at 
80°C in the dark for 15 min [10]. 
RESULTS 
Optical Absorption Spectroscopy in Model Systems 
A characterization of anthralin and derivatives in human skin 
by optical absorption sp.ectroscopy requires the knowledge of 
the solvent effect and thus a study of the polarity, pH and 
hydJ'ogen bonding effects on t he anthralin absorption spectrum 
since literature data are rather scarce [3, 5]. 
The absorption spectra of anthralin , 1,8-dihydroxyanthraqui-
none and 1,8-1',8'-tetrahydroxydiantill'on in nonaqueous media 
a re given in Fig 1. In aqueous solutions the presence of ionizable 
hydroxyl groups on the anthracene ring, leads to the occurrence 
of an ionic equilibrium between the neutral and the monobasic 
form of antill'alin as evidenced on Fig 2A which shows an 
isobestic point (and thus the presence of only 2 species at 
equilibrium) at 360 nm. The pKa can be determined accurately 
enough from Fig 2B data although the low solubility of an-
thralin at neutrality and its unstability at pH > 12 imposes the 
spectral analysis in the pH range 7-12. This pKa is found to be 
9.4 in complete disagreement with previous determination [11] 
which in 75% dioxane-25% water mixtures led to pKa = 13.06. 
However, the entirely different medium conditions do not allow 
direct comparison between these 2 values. It turns out that the 
1,8-dihydToxyantill'aquinone pKa is also found to be 9.4. We 
have no explanation at hand for this similaJ"ity. 
In conclusion, since the poor solubili ty of the dianthron (III) 
precludes any valuable pKa determination, these ionic equilib-
ria can be depicted as follows. 
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FIG 1. A, Absorption spectrum of anthralin (20°C) in (---) 
aqueous solution (pH 7.5) (- - - ) acetone or chloroform (-.-) ethanol. 
B, Absorption spectrum of I,B-dihydroxyanthraquinone (---) and 
1,B-l ',B'-tetrahydroxydianthron (- - -) in ethanol (20°C) . 
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It is interesting to note that in contrast with the optical 
absorption spectra recorded in chloroform or acetone, the one 
recorded in ethanol shows a shoulder at - 392 nm indicating, in 
neat ethanol, a low concentration of the basic form of anthralin 
(Fig 1) . The stabilization of ionic species in a nonionizing solvent 
like ethanol is not unusual since it occurs for instance with 
quinoline derivatives [12]. It has been attributed to strong 
hydl'ogen bonding of solvent molecules with weakly acidic 
groups. In aprotic solvents like the basic dimethylformamide 
(DMF) [5], the absorption spectrum of the anionic anth ralin is 
obtained (Fig 2) while in DMSO both the neutral and anionic 
form are present (Fig 2). 
Fluorescence Studies on Anthralin and Oxidation Products 
Neutral aqueous anthl'alin solu tions do not fluoresce. Increas-
ing the pH leads to the appearance of a fluorescence emission 
the excitation spectrum of which clearly corresponds to the 
absorption of the antill-alin monoanion. Upon excitation at 450 
nm which selectively excites the monoanion, the fluorescence 
quantum yield reaches 0.1 at pH 9.4 as measured using the 
fluorescein emission as standard [13]. In DMF, as expected in 
view of the absorption properties in this solvent, the same 
fluorescence emission is recorded (Fig 3) but the fluorescence 
quantum yield is dJ"amatically increased (qW = 0.7). the nUOl'es-
cence quenching observed in basic aqueous medium as com-
pared with the same emission in DMF is due to strong inter-
actions between antill'alin monoanions in their fU'st excited 
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FIG 2. A, Absorption spectrum (20°C) of aqueous anthralin at: 
(- - ) pH 7.55; (xxx) pH B.lO; (- - -) pH 9.00; (. .. ) pH 9.B; 
(_._._) pH 11.0. B, Titration curve of 5 x lO-r, M anthralin in 5 X 10-2 
M Tris buffer determined from absorbance at 3B4 nm (€ = IB,OOO M - ' 
em for the anthralin anion). C, Absorption spectrum (20°C) of 5 x lO-r, 
M anthralin in (--) DMF; (- - -) DMSO. 
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FIG 3. Corrected fluorescence excitation (emission set at 500 nm) 
and emission (upon excitation at 450 nm) pectra of anthralin in DMF. 
The emission intensity is 70 times lower in acetone which leads to the 
same spectrum. Temperature 4°C. 
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FIG 4. Anthralin autooxidation in buffered solutions at pH lOA; [0, ] 
= 2.65 X 10- " M. Solu tions were kept in the dark: temperature 20°C. 
Inset: Kinetics of anthralin oxidation in ethanol (0-0), pH lOA buffer 
( _-0), dimethylformamide (0-0) measured at 388 nm. Anthralin, 
concentration: 2.5 X 10-" M. 
singlet state (from which the fluorescence emission arises) and 
the strongly polar water molecules, leading to nonradiative 
deactivation as shown by studies with other aromatic molecules 
such as indole derivatives [14]. 
A weak anthralin monoanion fluorescence emission is ob-
served in ethanol and an even weaker one in acetone, confirming 
the optical absorption properties and the presence of monoan-
ionic anthralin in these hydrogen bond-forming solvents. The 
excitation spectrum of this fluorescence emission corresponds 
to the absorption spectrum of the anionic species ruling out 
that an excited state proton transfer is responsible for the 
fluorescence emission [15] since in this case the fluorrescence 
excitation spectrum would correspond to the absorption spec-
trum of the neutral species. 
The oxidation products II and III do not fluoresce in the 
present experimental conditions. 
Effect of Solvent, pH, Light and Complex Formation on the 
Stability of Anthralin 
There are some reports on the stability of anthralin. However 
they suffer from a major flaw, i.e., their qualitative aspects. For 
instance the solvent and light effects are not satisfactorily 
separated leading to somewhat confusing data [5,16] on the 
anthralin instability. This oxidation has been shown to involve 
free radicals and possibly 0 2-radicals [17]. 
Effect of solvent and pH: Although anthralin is fairly stable 
in chloroform, it is slowly oxidized in alcohol, acetone or in 
neutral aqueous solutions where the oxidation rate increases 
with increasing pH. In dimethylformamide and basic solutions 
the oxidation is very fast, leading in the primary step to the 
dihydroxyanthraquinone (II) which is fairly stable in basic 
media where it slowly decomposes into further products, among 
them compound III and other unknown compounds related to 
the so-called anthralin brown [4]. The kinetics of this oxidation 
reaction is first order (Fig 4) at low anthralin concentration 
which can be simply explained by the following scheme. 
_ kl 
I + O2 -+ Products (1) 
. d[r] _ 
leadmg to - ---cIt = kl[02][I ] (2) 
In our experimental conditions [r] "" 1-3 X 10- 5 M and under 
ai.r saturation, [02] "" lO[r] so that (2) can be represented as a 
pseudo fIrst order reaction characterized by a lifetime T = 1/ 
k l [02]. 
In the Table the reaction rate constant for the anthralin 
oxidation in various solvents is given. 
From data in the table it can be concluded that the autooxi-
dation of the monobasic species is much more rapid than the 
neutral one and is rate determining in mixtures of both species 
at equilibrium. It can thus be suggested that in alcoholic solu-
tions the autooxidation still proceeds via the monoanionic spe-
cies formed at low concentration as shown by fluorescence 
spectroscopy. The general scheme for the autooxidation of 
anthralin could be described as: 
I K 1- + O2 b Products (3) 
K is the stability constant of the 1- species in the nonaqueous 
medium and kl is the bimolecullu reaction rate constant of (eq. 
1): 
_ dW] = klW][Oz] 
dt 
- K d[I] = Kk l [I][02] dt 
d[I] 
- dt = k l [I][02] 
(4) 
(5) 
(6) 
The reaction rate constant for the autooxidation of anthralin in 
ethanol is given in the Table. 
Effect of light: In contrast with the autooxidation in the dark 
both the neutral and the monoanionic species are readily oxi-
dized (Fig 4) by UV or visible light. As shown on Fig 5 in 
ethanolic solutions, the presence of good isosbestic points sug-
gests that there is a single photooxidatin product, namely the 
dihydroxyanthraquinone. The same considerations apply to 
neutral or basic aqueous solutions although in basic solution 
the photooxidation leads to the formation of the monobasic 
form of the dihydroxyanthraquinone (II) . The photooxidation 
quantum yields (i.e. the number of anthralin molecules oxidized 
per absorbed quantum) under various experimental conditions 
are given in the Table. They are reasonably high with respect 
Solvent 
TABLE Characteristics of anthralin oxidation 
DMF, H,O (pH lOA) or Ethanol 
H,O + 1.4 X JO- ' M HSA 
0.5 M-1sec ' 0.05 M 'sec' 
5 X lO- a 
Irradiation wavelengths: 
404 and 437 nm 
4 X 10-" 
Irradiation wavelengths: 
>320 nm 
Second order rate constant (k,) for the autooxidation and quantum 
yield (<1» for the photooxidation of anthralin in various conditions at 
20°C. rOd = 2.65 X 10- 4 M in an air-saturated H20 and 2.07 X 10-" M 
in air-saturated ethanol. 
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FIG 5. Photodegradation of 3.5 x 10- 0 M anthralin in ethanol: 1,.", 
= 4.9 X 10-" einstein sec- I. Temperature 20°C. [0"] = 2.07 X 10- " M 
(air saturated ethanol). 
1 5 -1 
QD T K.=2J.1O M 
n:l 
2 0 
Q.6 
tS 
US 1. 2 
[Nlr~'ll-5) 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
~ 500 600 
~(nm) 
FIG 6. Absorption spectra (20°C) of anthralin (--- ) and 1,8-
dihydroxyanthraquinone (- - -) bound to HSA in pH 7.4 Tris buffer. 
Inset: Benessi-Hildebrand reciprocal binding plot for the anthralin 
HSA complex. 
to most common photo oxidation encountered in biological sys-
tems [18]. 
As shown on Fig 5, the photooxidation is a first order process, 
which must be expected in view of the short lifetime of the 
excited states of organic molecules produced by the excitation 
with visible light. It is also consistent with the small molar 
extinction coefficient and the weak light intensity used in steady 
state irradiations [13]. 
Spectroscopic Investigation of the Interaction of Anthralin 
and Derivatives with Albumin and DNA 
Albumin: Addjtion of HSA or BSA to a buffered neutral 
aqueous anthralin solution leads to a bathochromic shift of the 
anthralin absorption and the appearance of the characteristic 
absorption of the monobasic species (Fig 6) indicating complex 
formation between albumin and anthralin. Similarly the 1,8-
dihydroxyanthraquinone (II) binds to HSA leading to the 
monoanionic species. On the other hand, the dimeric species 
(compound III) does not form complexes with HSA. 
DNA: The slow decomposition of the neutral species in 
neutral aqueous solutions (see above) has some important 
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consequences. The apparent shift of the anthralin absorption 
spectrum in presence of DNA in neutral aqueous solutions 
occurring after incubation times up to 20 hr [19,20] is not 
necessarily due to binding of anthralin to DNA but rather to 
the slow oxidation of anthralin. Thus, no optical absorption red 
shift can be detected at either room (20°C) or high temperature 
(65°C) (where DNA is either native or denatured) when exper-
iments are peformed with deaerated mixtures. In addition, in 
deaerated solutions, there is no apparent increase in the solu-
bility of anthralin at neutral pH in presence of 0.1 % DNA. 
Stability of the Albumin-Anthralin Complex: Since the bind-
ing of anthralin to HSA results in the formation of the mono-
basic anthralin, anthralin is readily oxiilized (see Table, Figs 4-
6) either in the dark or upon excitation with UV and/or visible 
light yielding again the 1,8-dihydroxyanthl'aquinone (com-
pound II) which binds to HSA where it is stabilized as the 
monoanion. This latter species slowly oxidizes leading to brown 
products. 
Spectroscopic Investigation of Anthralin Stability in Human 
Epidermis 
It has been shown in the preceding section, that anthralin 
binds to proteins such as serum albumins. It can thus be 
anticipated that binding to proteins occurs when antill'alin is 
applied on human skin. The absorption spectra of intact human 
epidermis samples (Fig 7) treated with anthralin show the 
presence of strong absorptions in the 400-600 nm region indi-
cating the formation of oxidation products. Their nature de-
pends on the time elapsed after the topical application and not 
on the mode of application (i.e., 0.5% anthralin in cream or in 
acetone). The shape of the absorption spectrum suggests the 
formation of the dihydroxyanthraquinone as the primal'y prod-
uct since it gives rise to an absorption maximum in the 500 nm 
region when bound to protein. 
The strong absorption band in the 380 nm region strongly 
suggests that unoxidized anthralin is still present in human skin 
24 hI' after topical application. In support to this hypothesis in 
vitro experiments show that incubating epidermis with 5 x 10- 5 
M antill'alin (prepared as a 2% stock solution in acetone) in 
Hanks' medium leads to an absorption spectrum (and thus to 
products) not essentially different, after 3 hr (except in the 
relative proportion of oxidized versus unoxidized anthralin), 
from those obtained with in vivo topical application (Fig 7). 
Moreover unoxidized anthralin can be still clearly identified in 
human skjn 24 ill' after incubation by its fluorescence emission. 
As shown on Fig 8 where, besides an unidentified fluorescence 
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FIG 7. A, Absorption spectrum of a normal skin epidermis incubated 
for 3 hI' with 10- 4 M anthralin in Hanks' medium. B, Absorption spectra 
of a nonpsoriatic patient skin epidermis treated with 0.5% anthralin 
cream or acetone solution. (---) Trea tment before blister formation, 
(- - -) trea tment after blister format ion. Tempera tUJ'e in all cases: 
20°C. 
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FIG 9. Absorption spectra of suction blister fluid (measured at 
20°C). A, Doped wi th 5 x 10- " M anthralin; - -- immediate ly a fter 
addition; - - - 4 days after additioil. B , Doped with 5 x 10-" M, 1,8-
dihydroxyanthraquinone. 
emission, the presence of the characteristic fluorescence maxi-
mums at 510, 550, and 600 11m a nd the fluorescence excitation 
spectrum corresponding to the absorption spectrum well char-
acterize the anthralin monoanion. 
The GeMS Detection of Anthralin and 1,B-
Dihydroxyanthraqu.inone in Suction Blister Flu.id 
Anthralin and dihydroxyanthraquinone can be easily identi-
fied in suction blister fluid doped with known amounts of these 
derivatives (Fig 9). Interestingly enough, absorption spectros-
copy shows that, in this case, both compounds bind to albumin 
which constitutes an important component of the interstitial 
flu id [9]. Such a binding leads, of course, to a fast oxidation of 
anthralin as observed in model buffered albumin solut ions 
because of the antlu-alin monoanion formation a nd its easy 
oxidation. 
Such solutions a lso r epresent excellent standards for a frag-
mentation study and characterization by GeMS. As already 
reported [10] anthralin a nd 1,8-dihydroxyanthraquinone but 
not the "antlu 'alin dimer" (III) can be identified by mass 
spectrometry provided t hey ar e stabilized as trimethylsilyl de-
rivatives after chromatography (see Experimental section) . In 
these conditions, the retention t imes ar e 6.9 mn and 7.9 mn for 
tri-TMS-anthralin and bis-TMS-l , 8-dihydroxyanthraquinone 
respectively (see Experimental). Their mass spectrum (Fig 10) 
reveals characteristic ions at ml e = 442 (anthralin) and m/ e = 
369 (l ,8-dihydl'Oxyanthraquinone) allowing t hei.r determination 
and quantification using t he single ion moni toring technique 
(SIM). The lowest concentration that can be detected using 
this technique is 0.04 X 10- 10 M [10). 
SIM centered on ml e = 442 a nd 369 a nd carried out on 
silylated derivatives makes it possible to detect without, of 
course, any difficulties 10- 5 M anthralin and 1,8-dihydroxyan-
thraquinone in 500/-t1 of doped suction blister fluid (Fig 11) . On 
the other hand, the same determination carried out on suction 
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of sily lized ) ,8-dihydroxyanthraquinone. 
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blister fluids obtained from suction blisters done on in tact 
human skin topically t reated with anthralin does not provide 
any evidence for th ese derivatives. 
DISCUSSION 
For the sake of clarity the basic physicochemical properties 
of a nthralin have been discussed along with the presentation of 
the results. Because of its obvious biological implications, the 
complex formation with human serum albumin deserves much 
attentio n. This complexation with H SA was studied according 
to a Scatchard a na lysis [21]: 
v 
- = K(n - jj) 
C 
(7) 
where ii is the concentration ratio between bound anthra lin 
and the protein, C is the concentration of unbound anthralin 
and n the average number of bound anthralin molecules per 
protein molecule. The molar extinction coeffici ent a nd thus the 
concen tration of bound a nthralin was obtained from the frac-
tion of light abso rbed at 398 nm at saturation of t he macro-
molecule by the a nthralin ligand . 
A Benessi-Hildebrand reciproca l bind ing plot is presented 
in inset of Fig 6 leading to K = 2.3 X lOr, M - 1 with one binding 
site. It must be noted that at high (anthralin) / (HSA) molar 
ratios the same analysis shows that a nthralin can occupy on 
the average 2.5 sites. A similar associat ion constant was found 
for the 1,8-dihydroxyanthraquinone. This resul t, with the fact 
t hat the monoanion is form ed upon complexation, suggests that 
these 2 molecules bind to the same site on HSA. This indicates 
that the binding 's ite has a high proton affinity corresponding 
to a local pH shift of about 2 pH units with respect to the 
buffered aq ueous so lutions. 
Thus, provided anthralin passes t hrough the epidermis 
dur ing a n acute infla mmatory response, its fast binding to HSA 
con tained in the interstitial fluid [9] induces a n almost instan-
taneous oxidation to dihydroxyanthraquinone which t hus could 
be be lie~ed as dil"ecting t he metabolic path, leading to the 
a nthra lin degradation products found in biologica l tluids. · On 
the other ha nd, the spectral shift observed in aerated mixtures 
of ant hralin a nd DNA is clearly shown not to be a proof of 
DNA-anthralin complex form a tion [19, 20]. Such studies re-
qu ire a naerobic condi t ions and more ela borated and sensit ive 
techniques than opt ical absorption measurements. In addition , 
it must be noted t hat quinacrine (which binds to DNA) a nd 
anthra lin inhibit UV-induced DNA repa ir at different steps by 
different mecha nisms [22]. 
The presence of t he monoanionic species in human skin as 
clearly shown by tluorescence spectroscopy revea ls that at least 
som e anthra lin binds to skin proteins at sites whose structures 
a re close to those found in albumin. One may al'gue it is 
somewhat surpris ing that anthralin, which is fa irly unstable in 
aerated so lu tions especially in the monoa nionic form, is much 
more stable in air-exposed human epidermis. In fact, it is well 
establisli ed that oxygen diffusion in proteins does not follow the 
s impl e diffusion kinetics observed in solu tions so that molecul es 
that a re buried in protein structure a re not full y accessible to 
oxyge n. Liver alcohol dehydrogenase [23] or chymotl'ypsin [24] 
are good examples of such properties s ince the phosphorescence 
of a tryptopha n residue of the protein or the phosphorescence 
of an extrinsic chromophore (benzophenone) bou nd to the 
protein can be detected at room temperature in aerated solu -
tion, a lthough the characte ristic property of a phosphorescence 
emission is to be quenched by oxygen. 
It must be noted that t he absence of a nthralin in suct ion 
blis te r after topica l application is in agreement with a strong 
binding of a nthralin to skin s tructures impeding important 
diffus ion towards dermis t hrough the intersti t ia l fluid. This is 
also in agreement with previous studi es [25] showing that most 
of the ointment a nd its ingredients remains a t t he surface of 
Vol. 80, No . 1 
the skin although the na ture of the ointment does intluence the 
penetration into the epidermis [25]. However it must be stressed 
that our negative result on the anthl'alin content of the blister 
tluid has been obta ined after topical application on healthy 
skin. Such a study should be extended to psoriatic patients 
showing skin lesions. 
We wish to thank Drs. B. S hroot and J . Ma ignan for a generous gift 
of purified a nthra lin and der ivatives. 
REFERENCES 
I. Christophersen J, Gammeltoft M: Dithranol-en overs igh t. Arch 
Pharm Chem 85:5fi6-575, 1978 
2. Swa n beck G, Hilstrom L: Ana lys is of etiological factors of squamous 
cell skin cancer of different loca tions. 4. Concluding remarks. 
Acta Dermatovener (Stockh) 51:151- 156, 1971 
3. E lsabbagh HM , Whi tworth CW, Schramm LC: Separation, ident i-
fi cation a nd qu ant ita tion of anthra lin and its decomposition 
products. J Pharmaceutical Sci 68:388-390, 1979 
4. colin M, Ma igna n J , Lang G, S hroo t B: An thra lin ox ida tion prod-
ucts: Role of the C II,-methy lene and ph enol groups. Br J D ermatol 
105(suppl 20) :59-(;0, 1981 
5. Haab WP, Gmeiner BM: lnllu ence of ultrav iolet light, various 
tempera tures a nd zinc ions on a nthralin (dithranol). Dermatolo-
gica 150:267-276, 1975 
fi . Haab W, S iber H: Glucose-6-phosphat-dehydrogenase und externe 
antipsoria tica. Arch Dermatol Forsch 249:179- 1.89, 1974 
7. Dubert ret L, Santus H, Bazin M, De Sa e Melo MT: Photochem-
istry in human epidermis: A quant itative approach. P hotochem 
Ph otobioI 35:103- 108. 1982 
8. Everett M, Yeargers E. Sayre HM, Olson HL: Penetration of 
epidermis by ultrav iolet rays. Photochem Photobiol 5:533- 541. 
1966 
9. Vermer BJ , Heman HC, Van Gent CM: The determination of lipids 
a nd prote ins in suction blis te r Iluid. J Invest De rmatol 73:303-
305, 1979 
10. Prognon 1', Gond A, Dubertret L, Mahuzie r G: S ilylation du dith-
ranol e t de ses derive d 'oxydation. Ann Pharm Fra nc, in press 
11 . Kido H , Conard-Fernelius W, Haas CG: Stud ies on coo rdina t ion 
compounds: XV.ll1. Fo rmation constants of so me meta l sa lts of 
hydroxyquinones. Anal Chim Acta 23:116- 123, 1960 
12. Pileni MP. Giraud M, Santus R Kynurenic ac irl . 1. S pectroscop ic 
properties. Photochem Photobiol 30:251-256, 1979 
13. Parker CA: Photoluminescence of Solu tions. Elsevier, 1968, pp 265 
14. Santus R , Bazin M, Auba illy M: Nature, ident ification and prop-
ert.i es of in termed iates produ ced by UV excita tion of indole 
derivatives at low a nd room temperature. Some a pplications to 
tryptophan-conta ining proteins. Hev Chem Intermed 3:231- 283, 
1980 
15. Wiegrebe W, Hetzow A, P lumier K Anthralin and its acety l esters: 
S pectroscopic properties and enzyme inhibitory ac tivi ty. Br J 
Dermatol 105(suppI 20):1 2-14 , 1981 
](). Cavey D, Ca ron J C, Shroot; B: Anthralin: Chemical ins tabi li ty and 
glucose-f)- phosphate dehydrogenase inhibi tion. Br J Dermato l 
105(suppI 20):1 5- 19.1981 
17. Martinmaa J, Muselius J , Mus(,a kallio KJ<: Free radicals by au-
tooxidation of anthra lin and its 10-acyl analogues. Br J Dermatol 
105(suppl 20):52-53, 1981 
18. Gollnick J<: Chemica l aspects of photody na mic action in the pres-
ence of moleculru' oxygen, Hadia tion Resea rch, Proceedings of 
the Fifth in ternational Congress of Radiation Research. Ed ited 
by OF Nygaard , I-IJ Adler, WK S incla ir. New York, Academ ic, 
1975 
19. wanbeck G: In te raction between deoxyribonucle ic ac id a nd so me 
anthracene and anthraquinone derivatives. Biochim Biophys 
Acta 123:630-i533, 19(;6 
20. De Sa e Melo M1' , Sa ntus H, Dubertret L: Physico-chemical 
properties a nd s ta bility of anthra lin in in teraction with a lbumin, 
in suction blis ter Iluid and intact huma n epiderm is. B r J Der-
matol 105(suppl 20):20-23, 198 1 
21. Scatchard D: The a ttradion of proteins for small molecules and 
ions. Ann Acad Sc i NY 51:660-672, 1949 
22. Kulta rni MS, Yielding KL: Inhibitionn of UV -induced DNA repa ir 
at d iffe rent steps by quinac rine a nd anthralin. Biochem Biophys 
Hes Comm 83:1 53 1- 1537,1978 
23. SavioU.i ML, Ga lley WC: Room temperature phosphorescence and 
the dyna mic aspects of protein s tructure. Proc Nat Acad Sci 
71:41 54- 41 58, 1974 
24. Gioannini 1'L, Campbell P: An extrins ic room t.e mperature phos-
phorescent probe. Hemarkable shielding of benzophenone triplet 
at the active s ite of chymotrypsin. B iochem Biophys I~es Comm 
96:106- 1l3,1980 
25. Kammerau B, Zech A, Schaefer H : Absolu te concentration of 
dithranol and triacetyl-dithl'anol in the skin layers afte r local 
treatment: "in vivo." J Invest Dermatol 64: 145-149, 1975 
